ArticleTherapeutic advances in ophthalmology
Quality of life and its determinants among glaucoma patients attending Berhan Aini Ophthalmic National Referral Hospital: A cross-sectional study.
Article in Therapeutic advances in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glaucoma is a leading cause of irreversible blindness, and its increasing global prevalence profoundly affects patients' physical, psychological, and social well-being. While clinical measurements are essential, they do not fully capture the disease's subjective impact on daily life. This highlights the need for patient-reported outcomes, such as health-related quality of life (HRQoL). Objectives: This study aimed to linguistically and psychometrically validate the Eritrean version of the Glaucoma Quality of Life-36 (GlauQoL-36) questionnaire and to assess HRQoL and its determinants among glaucoma patients in Eritrea. Design: A cross-sectional study was conducted among glaucoma patients attending the Berhan Aini Ophthalmic National Referral Hospital in Asmara, Eritrea, between August and November 2024. Methods: A systematic random sampling technique was used to enroll participants. Data were collected through structured interviews using the Eritrean version of the GlauQoL-36. The tool was linguistically and psychometrically validated. Analysis of Co-variance (ANCOVA) was employed at the multivariable level to assess the determinants of HRQoL using generalized linear model in Statistical Package for Social Sciences (SPSS) (version 26.0). Reliability, confirmatory factor analysis and the error plot were performed in R Studio (version 4.4.3). Results: A total of 306 respondents with a mean age of 65.1 (Standard Deviation (SD): 11.9) years were included. The confirmatory factor analysis demonstrated an acceptable model fit, with a root mean square error of approximation (RMSEA) of 0.064, and strong fit indices for comparative fit index (0.973) and Tucker-Lewis index (0.970). The overall internal consistency of the 33-item tool (excluding the driving domain) was excellent, with a Cronbach's alpha of 0.89. The overall mean HRQoL score was 74.05 (SD: 13.71) out of 100. The constraint domain had a significantly higher ( Conclusion: The Eritrean GlauQoL-36 is a valid, reliable tool for assessing patient-reported outcomes. The disease significantly impairs daily functioning and psychosocial well-being, highlighting the need for holistic, patient-centered care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.